Medable

Medable, Inc. is a SaaS company based in Palo Alto, California, founded in 2015. The company aims to enhance access to effective therapies by transforming clinical trials through a global cloud-based platform designed for decentralized and hybrid trials. Medable has experienced significant growth, deploying its solutions in over 400 trials across 70 countries and serving more than 1 million patients and over 120 companies, primarily in the US and Europe. The Medable platform supports comprehensive decentralized trial processes, including remote screenings, patient monitoring, digital consent, and telemedicine visits. It features AI-powered tools for electronic clinical outcomes assessment (eCOA) to streamline data collection and insights. Key offerings include eCOA+, Total Consent for digital engagement, and Studio, a no-code/low-code tool for customizing trial experiences. Medable collaborates with mid-to-large pharmaceutical companies, emerging biopharma, and contract research organizations, facilitating partnerships across the healthcare sector.